Keyphrases
Development Implementation
100%
Therapy Development
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Development Design
100%
Chimeric Antigen Receptor Therapy
100%
Therapeutic Design
100%
Natural Killer Cells
37%
Hematological Malignancies
12%
Solid Tumors
12%
Cancer Treatment
12%
Chronic Disease
12%
Immune Cells
12%
Bench to Bedside
12%
Natural Killer Cell Therapy
12%
Large Population
12%
High Specificity
12%
Possible Sources
12%
T Antigen
12%
Promising Strategies
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
100%
Chronic Disease
7%
Solid Malignant Neoplasm
7%
Hematologic Malignancy
7%
Diseases
7%